Full Text View
Tabular View
No Study Results Posted
Related Studies
Modafinil for Treatment of Cognitive Dysfunction in Schizophrenia
This study is currently recruiting participants.
Study NCT00423943   Information provided by University of California, Davis
First Received: January 16, 2007   Last Updated: February 12, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Schizophrenia
Schizoaffective Disorder
Additional conditions recognized in this trial
Cognition Disorders
Psychotic Disorders
More general conditions related to this trial
Delirium, Dementia, Amnestic, Cognitive Disorders
Mental Disorders
Schizophrenia and Disorders with Psychotic Features
Interventions listed in this trial
modafinil
More general drug interventions related to this trial
Central Nervous System Agents
Central Nervous System Stimulants
Neuroprotective Agents
Pharmacologic Actions
Physiological Effects of Drugs
Protective Agents
Therapeutic Uses
Sponsors listed in this trial
University of California, Davis


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services